实用试验评估模拟培训对初级医生对老年人高风险处方的影响
Julie C Lauffenburger1,2, Matthew F DiFrancesco3, Gauri Bhatkhande1,2
1Center for Healthcare Delivery Sciences (C4HDS), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Journal of the American Geriatrics Society
|March 8, 2024
概括
模拟训练并没有减少老年人处方高风险药物. 然而,它确实减少了"按需要"的订单,这表明实习生对护理的更多所有权.
科学领域:
- 医学教育 医学教育
- 老年医学 老年医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高风险药物 (二,镇静催眠药,抗精神病药) 经常被处方给住院的老年人,这与指导方针相反.
- 现有的干预措施还没有充分探索医生在压力或认知负载下做出决策.
- 模拟培训对过度处方的影响尚未评估.
研究的目的:
- 评估沉浸式模拟培训在降低高风险药物处方在内科住院医生的有效性.
- 评估模拟对年龄较大的成人住院患者的二类药物,镇静催眠药和抗精神病药物处方模式的影响.
主要方法:
- 一个双臂实用试验随机分配了40名内科住院医生参加模拟培训或在线教育.
- 主要结局测量了对以前没有接受过治疗的老年人高风险药物的新处方.
- 电子健康记录被用来收集居民服务期间的数据,并使用通用估计方程进行分析.
主要成果:
- 干预组和对照组之间新高风险药物处方的总数没有显著差异 (比率比:0.85).
- 干预组显示",按需要" (PRN) 的高风险药物订单显著减少 (率比:0.29).
- 在干预组中观察到更多"一次性"订单的趋势,但这在统计学上并不显著.
结论:
- 模拟训练并没有减少住院老年人高风险药物处方的总数.
- 干预影响了处方行为,导致PRN订单减少,并可能增加医生对护理的拥有权.
- 未来的干预措施应纳入从这项研究中对处方模式和实施教训的见解.
更多相关视频
05:04Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
Published on: August 9, 2024
919
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.1K
相关概念视频
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
